Case Note & Summary
The dispute arose from a challenge by Indian Drugs & Pharmaceutical Ltd. (IDPL) against a judgment of the Delhi High Court that quashed a rate contract awarded to IDPL for the supply of Oral Contraceptive Pills (OCPs). The respondents, Famy Care and another, contended that the rate contract violated the tender notice and the Purchase Preference Policy, which specified that only certain brands of OCPs were eligible for direct procurement by the Union of India. The High Court found that the policy was clear in its intent to limit purchases to Mala D and Mala N, rejecting the argument that the policy was illustrative and could include other brands. The Supreme Court upheld the High Court's interpretation, stating that the explicit mention of the brands in the policy indicated a clear restriction. The court dismissed the appeal, confirming the High Court's judgment without costs.
Headnote
A) Administrative Law - Judicial Review - Interpretation of Purchase Preference Policy - Core Legal Point - Purchase Preference Policy, 2006 - The High Court held that the Purchase Preference Policy applied only to specific brands of Oral Contraceptive Pills, namely Mala D and Mala N, and not to other brands, thus quashing the rate contract awarded to the appellant. The court emphasized that the explicit mention of these brands indicated a restrictive interpretation of the policy (Paras 6-10).
Issue of Consideration
Whether the High Court correctly interpreted the Purchase Preference Policy and the validity of the rate contract awarded to the appellant.
Final Decision
The Supreme Court dismissed the appeal, confirming the High Court's judgment that quashed the rate contract awarded to IDPL for violating the Purchase Preference Policy.
Law Points
- Interpretation of tender documents
- Purchase Preference Policy
- validity of rate contracts
- judicial review of administrative decisions
